We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
3.40 | 0.20% | 1,708.60 | 1,708.60 | 1,708.80 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
1,713.00 | 1,699.40 | 1,701.60 | 11,522,668 | 16:29:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.27 | 70.34B |
Date | Time | Source | Headline |
---|---|---|---|
26/3/2024 | 15:30 | UK RNS | GSK PLC Director/PDMR Shareholding |
25/3/2024 | 13:00 | UK RNS | GSK PLC Notice of AGM |
22/3/2024 | 16:20 | UK RNS | GSK PLC Transfer of Treasury Shares |
22/3/2024 | 15:36 | UK RNS | GSK PLC Director/PDMR Shareholding |
18/3/2024 | 09:30 | UK RNS | GSK PLC New Phase III Jemperli data in endometrial cancer |
18/3/2024 | 08:47 | ALNC | GSK says Jemperli combination gets good results for endometrial cancer |
13/3/2024 | 15:48 | UK RNS | GSK PLC Director/PDMR Shareholding |
08/3/2024 | 17:12 | UK RNS | GSK PLC Board Committee Change |
07/3/2024 | 09:38 | ALNC | GSK observes positive data in Blenrep trial for blood cancer treatment |
07/3/2024 | 07:00 | UK RNS | GSK PLC GSK announces positive Blenrep DREAMM-8 results |
1 Year Gsk Chart |
Intraday Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions